Stress-induced neuroinflammation: Mechanisms and new pharmacological targets

Brazilian Journal of Medical and Biological Research

Volumn 41, Issue 12, 2008, Pages 1037-1046

  Munhoz, C D ^a   Garcia Bueno B ^b   Madrigal, J L M ^b   Lepsch, L B ^a   Scavone, C ^a   Leza, J C ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b SCHOOL OF MEDICINE   (Spain)

Author keywords

Cyclooxygenase; Nitric oxide; PPAR ; Stress induced neurodegeneration

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; BB 1101; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; CYTOKINE; DIZOCILPINE; EXCITATORY AMINO ACID; FLUOXETINE; GLUCOCORTICOID; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; OXIDIZING AGENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN J2; PYRROLIDINE DITHIOCARBAMATE; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

AGING; ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; BRAIN DAMAGE; BRAIN ISCHEMIA; CLINICAL TRIAL; CYTOKINE RELEASE; DEGENERATIVE DISEASE; DRUG MECHANISM; DRUG MEGADOSE; DRUG TARGETING; ENCEPHALITIS; FUNCTIONAL DISEASE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NEUROPATHOLOGY; NEUROPROTECTION; NEUROPSYCHIATRY; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PROTEIN EXPRESSION; REVIEW; STRESS;

ANIMALIA;

EID: 62749188778     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2008001200001     Document Type: Review

References (60)

1. Cannon WB. Bodily changes in pain, hunger, fear and rage: An account of recent researches into the function of emotional excitement. New York: Appleton; 1915.
2. Selye H. A syndrome produced by diverse nocuous agents. Nature 1936; 138: 32.
3. Moghaddam B. Stress preferentially increases extraneuronal levels of excitatory amino acids in the prefrontal cortex: comparison to hippocampus and basal ganglia. J Neurochem 1993; 60: 1650-1657.
4. Sapolsky RM. Why stress is bad for your brain. Science 1996; 273: 749-750.
5. McEwen BS. Protective and damaging effects of stress mediators. N Engl J Med 1998; 338: 171-179.
6. Esch T, Stefano GB, Fricchione GL, Benson H. Stress in cardiovascular diseases. Med Sci Monit 2002; 8: RA93-RA101.
7. McEwen BS, Sapolsky RM. Stress and cognitive function. Curr Opin Neurobiol 1995; 5: 205-216.
8. Lucassen PJ, Vollmann-Honsdorf GK, Gleisberg M, Czeh B, De Kloet ER, Fuchs E. Chronic psychosocial stress differentially affects apoptosis in hippocampal subregions and cortex of the adult tree shrew. Eur J Neurosci 2001; 14: 161-166.
9. Munhoz CD, Lepsch LB, Kawamoto EM, Malta MB, Lima LS, Avellar MC, et al. Chronic unpredictable stress exacerbates lipopolysaccharide-induced activation of nuclear factor-kappaB in the frontal cortex and hippocampus via glucocorticoid secretion. J Neurosci 2006; 26: 3813-3820.
10. Bremner JD, Vythilingam M, Vermetten E, Nazeer A, Adil J, Khan S, et al. Reduced volume of orbitofrontal cortex in major depression. Biol Psychiatry 2002; 51: 273-279.
11. Frohman LA. Clinical neuropharmacology of hypothalamic releasing factors. N Engl J Med 1972; 286: 1391-1397.
12. Sorrells SF, Sapolsky RM. An inflammatory review of glucocorticoid actions in the CNS. Brain Behav Immun 2007; 21: 259-272.
13. De Cristobal J, Madrigal JL, Lizasoain I, Lorenzo P, Leza JC, Moro MA. Aspirin inhibits stress-induced increase in plasma glutamate, brain oxidative damage and ATP fall in rats. Neuroreport 2002; 13: 217-221.
14. Lipton P. Ischemic cell death in brain neurons. Physiol Rev 1999; 79: 1431-1568.
15. Magarinos AM, McEwen BS. Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: involvement of glucocorticoid secretion and excitatory amino acid receptors. Neuroscience 1995; 69: 89-98.
16. Rothstein JD, Dykes-Hoberg M, Pardo CA, Bristol LA, Jin L, Kuncl RW, et al. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 1996; 16: 675-686.
17. Beart PM, O'Shea RD. Transporters for L-glutamate: an update on their molecular pharmacology and pathological involvement. Br J Pharmacol 2007; 150: 5-17.
18. Leza JC, Salas E, Sawicki G, Russell JC, Radomski MW. The effects of stress on homeostasis in JCR-LA-cp rats: the role of nitric oxide. J Pharmacol Exp Ther 1998; 286: 1397-1403.
19. Madrigal JL, Garcia-Bueno B, Caso JR, Perez-Nievas BG, Leza JC. Stress-induced oxidative changes in brain. CNS Neurol Disord Drug Targets 2006; 5: 561-568.
20. Lawrence MS, Sapolsky RM. Glucocorticoids accelerate ATP loss following metabolic insults in cultured hippocampal neurons. Brain Res 1994; 646: 303-306.
21. Dunn AJ, Wang J, Ando T. Effects of cytokines on cerebral neurotransmission. Comparison with the effects of stress. Adv Exp Med Biol 1999; 461: 117-127.
22. Dantzer R, Kelley KW. Twenty years of research on cytokine-induced sickness behavior. Brain Behav Immun 2007; 21: 153-160.
23. Wang CX, Shuaib A. Involvement of inflammatory cytokines in central nervous system injury. Prog Neurobiol 2002; 67: 161-172.
24. Black RA, White JM. ADAMs: focus on the protease domain. Curr Opin Cell Biol 1998; 10: 654-659.
25. Smith RA, Baglioni C. Characterization of TNF receptors. Immunol Ser 1992; 56: 131-147.
26. Hurtado O, Lizasoain I, Fernandez-Tome P, Alvarez-Barrientos A, Leza JC, Lorenzo P, et al. TACE/ADAM17-TNF-alpha pathway in rat cortical cultures after exposure to oxygen-glucose deprivation or glutamate. J Cereb Blood Flow Metab 2002; 22: 576-585.
27. Madrigal JL, Hurtado O, Moro MA, Lizasoain I, Lorenzo P, Castrillo A, et al. The increase in TNF-alpha levels is implicated in NF-kappaB activation and inducible nitric oxide synthase expression in brain cortex after immobilization stress. Neuropsychopharmacology 2002; 26: 155-163.
28. Munhoz C, Madrigal JL, Garcia-Bueno B, Pradillo JM, Moro MA, Lizasoain I, et al. TNF-alpha accounts for short-term persistence of oxidative status in rat brain after two weeks of repeated stress. Eur J Neurosci 2004; 20: 1125-1130.
29. Baldwin AS Jr. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 1996; 14: 649-683.
30. Bierhaus A, Wolf J, Andrassy M, Rohleder N, Humpert PM, Petrov D, et al. A mechanism converting psychosocial stress into mononuclear cell activation. Proc Natl Acad Sci U S A 2003; 100: 1920-1925.
31. Li N, Karin M. Is NF-kappaB the sensor of oxidative stress? FASEB J 1999; 13: 1137-1143.
32. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109-142.
33. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 1996; 271: C1424-C1437.
34. Madrigal JL, Moro MA, Lizasoain I, Lorenzo P, Castrillo A, Bosca L, et al. Inducible nitric oxide synthase expression in brain cortex after acute restraint stress is regulated by nuclear factor kappaB-mediated mechanisms. J Neurochem 2001; 76: 532-538.
35. Nogawa S, Zhang F, Ross ME, Iadecola C. Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage. J Neurosci 1997; 17: 2746-2755.
36. Vesce S, Rossi D, Brambilla L, Volterra A. Glutamate release from astrocytes in physiological conditions and in neurodegenerative disorders characterized by neuroinflammation. Int Rev Neurobiol 2007; 82: 57-71.
37. Domoki F, Perciaccante JV, Puskar M, Bari F, Busija DW. Cyclooxygenase-2 inhibitor NS398 preserves neuronal function after hypoxia/ischemia in piglets. Neuroreport 2001; 12: 4065-4068.
38. Iadecola C, Niwa K, Nogawa S, Zhao X, Nagayama M, Araki E, et al. Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice. Proc Natl Acad Sci U S A 2001; 98: 1294-1299.
39. Yamagata K, Andreasson KI, Kaufmann WE, Barnes CA, Worley PF. Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron 1993; 11: 371-386.
40. Tracey KJ. Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest 2007; 117: 289-296.
41. Feinstein DL. Therapeutic potential of peroxisome proliferator-activated receptor agonists for neurological disease. Diabetes Technol Ther 2003; 5: 67-73.
42. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J Biol Chem 1995; 270: 12953-12956.
43. Kainu T, Wikstrom AC, Gustafsson JA, Pelto-Huikko M. Localization of the peroxisome proliferator-activated receptor in the brain. Neuroreport 1994; 5: 2481-2485.
44. Moreno S, Farioli-Vecchioli S, Ceru MP. Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS. Neuroscience 2004; 123: 131-145.
45. Luna-Medina R, Cortes-Canteli M, Alonso M, Santos A, Martinez A, Perez-Castillo A. Regulation of inflammatory response in neural cells in vitro by thiadiazolidinones derivatives through peroxisome proliferator-activated receptor gamma activation. J Biol Chem 2005; 280: 21453-21462.
46. Sundararajan S, Jiang Q, Heneka M, Landreth G. PPAR-gamma as a therapeutic target in central nervous system diseases. Neurochem Int 2006; 49: 136-144.
47. Heneka MT, Landreth GE. PPARs in the brain. Biochim Biophys Acta 2007; 1771: 1031-1045.
48. Garcia-Bueno B, Madrigal JL, Lizasoain I, Moro MA, Lorenzo P, Leza JC. Peroxisome proliferator-activated receptor gamma activation decreases neuroinflammation in brain after stress in rats. Biol Psychiatry 2005; 57: 885-894.
49. Garcia-Bueno B, Madrigal JL, Lizasoain I, Moro MA, Lorenzo P, Leza JC. The anti-inflammatory prostaglandin 15d-PGJ2 decreases oxidative/ nitrosative mediators in brain after acute stress in rats. Psychopharmacology 2005; 180: 513-522.
50. Park EY, Cho IJ, Kim SG. Transactivation of the PPAR-responsive enhancer module in chemopreventive glutathione S-transferase gene by the peroxisome proliferator-activated receptor-gamma and retinoid X receptor heterodimer. Cancer Res 2004; 64: 3701-3713.
51. Garcia-Bueno B, Caso JR, Perez-Nievas BG, Lorenzo P, Leza JC. Effects of peroxisome proliferator-activated receptor gamma agonists on brain glucose and glutamate transporters after stress in rats. Neuropsychopharmacology 2007; 32: 1251-1260.
52. Garcia-Bueno B, Madrigal JL, Perez-Nievas BG, Leza JC. Stress mediators regulate brain prostaglandin synthesis and peroxisome proliferator-activated receptor-gamma activation after stress in rats. Endocrinology 2008; 149: 1969-1978.
53. Mouihate A, Boisse L, Pittman QJ. A novel antipyretic action of 15-deoxy-Delta 12, 14-prostaglandin J2 in the rat brain. J Neurosci 2004; 24: 1312-1318.
54. Smith AD, Castro SL, Zigmond MJ. Stress-induced Parkinson's disease: a working hypothesis. Physiol Behav 2002; 77: 527-531.
55. Esch T, Stefano GB, Fricchione GL, Benson H. The role of stress in neurodegenerative diseases and mental disorders. Neuro Endocrinol Lett 2002; 23: 199-208.
56. Luo L, Tan RX. Fluoxetine inhibits dendrite atrophy of hippocampal neurons by decreasing nitric oxide synthase expression in rat depression model. Acta Pharmacol Sin 2001; 22: 865-870.
57. Koo JW, Duman RS. IL-1beta is an essential mediator of the antineurogenic and anhedonic effects of stress. Proc Natl Acad Sci U S A 2008; 105: 751-756.
58. Munhoz CD, Kawamoto EM, de Sa Lima L, Lepsch LB, Glezer I, Marcourakis T, et al. Glutamate modulates sodium-potassium-ATPase through cyclic GMP and cyclic GMP-dependent protein kinase in rat striatum. Cell Biochem Funct 2005; 23: 115-123.
59. Scavone C, Munhoz CD, Kawamoto EM, Glezer I, de Sa Lima L, Marcourakis T, et al. Age-related changes in cyclic GMP and PKG-stimulated cerebellar Na,K-ATPase activity. Neurobiol Aging 2005; 26: 907-916.
60. Lepsch LB, Gonzalo LA, Magro FJ, Delucia R, Scavone C, Planeta CS. Exposure to chronic stress increases the locomotor response to cocaine and the basal levels of corticosterone in adolescent rats. Addict Biol 2005; 10: 251-256.